Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Carcinoma, Non-Small-Cell Lung 12Gliosarcoma 11Glioblastoma 11Prostatic Neoplasms 7Lung Neoplasms 6Head and Neck Neoplasms 6Breast Neoplasms 6Squamous Cell Carcinoma of Head and Neck 5Pancreatic Neoplasms 5Brain Neoplasms 4Astrocytoma 4Adenocarcinoma of Lung 3Wilms Tumor 2Uterine Cervical Neoplasms 2Sarcoma 2Salivary Gland Neoplasms 2Rectal Neoplasms 2Pinealoma 2Oligodendroglioma 2Meningioma 2Medulloblastoma 2Malignant mesenchymal tumor 2Liver Neoplasms 2Liposarcoma 2Leiomyosarcoma 2Histiocytoma, Malignant Fibrous 2Hemangiosarcoma 2Glioma 2Fibrosarcoma 2Ependymoma 2

Interventions

dehydroftorafur 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Platinum 1Immunoglobulin G 1Fluorouracil 1Disulfides 1Cisplatin 1Bevacizumab 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Stage II Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 × Radiotherapy, Conformal × Clear all
NCT00408694 2018-01-30

Bevacizumab, Cisplatin, Radiation Therapy, and Fluorouracil in Treating Patients With Stage IIB, Stage III, Stage IVA, or Stage IVB Nasopharyngeal Cancer

National Cancer Institute (NCI)

Phase 2 Completed
46 enrolled 10 charts
Head & Neck

Stage II Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7

Data powered by HemOnc (CC BY 4.0) Colophon âš¡